COSCIENS Biopharma Inc. is a Canada-based holding company. The Company is operating through its subsidiaries, including Ceapro Inc. (Ceapro) and Nualtis. Ceapro is focused on the development and commercialization of natural, plant-based active ingredients derived from oats and other renewable plant resources, using proprietary manufacturing and extraction technologies. Ceapro's primary active ingredient business activities relate to the development and commercialization of natural products for the personal care, cosmetic, human and animal health industries. Nualtis is a specialty pharmaceutical technology business focused primarily on proprietary oral thin-film drug delivery technologies. Its business model includes pharmaceutical formulation development, analytical and regulatory support services, contract development and manufacturing activities, partner-sponsored development programs and commercial product manufacturing.
Company Information
About this company
Key people
Key facts
- Shares in issue1.06m
- EPICCSCI
- ISINCA22112H2000
- LocationCanada
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCA$9.72m
- Employees28
- ExchangeToronto Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.